 MARSEILLE, France--BUSINESS WIRE--Regulatory News: Innate Pharma SA Euronext Paris: IPH; Nasdaq: IPHA Innate or the Company, today announced that the Company will hold a conference call on Tuesday, May 10, 2022 at 2 p.m. CEST 8 a.m. EDT, to give an update on business progress during the first quarter of 2022. Speakers during the call will be: Mondher Mahjoubi, Chief Executive Officer Joyson Karakunnel, Executive Vice President, Chief Medical Officer Yannis Morel, Executive Vice Pres 